Back
Day Range
$62.53
$66.20
52-Week Range
$32.00
$66.20
Volume
538,661
50D / 200D Avg
$47.48
/
$47.48
Prev Close
$61.92
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -84.1 | 0.3 |
| P/B | 40.7 | 2.9 |
| ROE % | -76.5 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$75.00
+18.1%
Forward EPS
-$2.57
Est. Revenue
0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
-$3.10
-$5.10 – -$1.60
|
49 M | 3 |
| FY2027 |
-$2.59
-$3.12 – -$2.00
|
10 M | 3 |
| FY2026 |
-$2.57
-$2.79 – -$2.35
|
0 | 2 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -23.69M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-76.46%
ROIC-36.74%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio11.77
Interest Coverage-45.77
Valuation
P/E Ratio
-84.08
P/B Ratio40.74
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -26.49M |
| ROE | -76.46% | ROA | -44.61% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -23.69M |
| ROIC | -36.74% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 11.77 |
| Interest Coverage | -45.77 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -84.08 | P/B Ratio | 40.74 |
| P/S Ratio | N/A | PEG Ratio | -4.04 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.23B | Enterprise Value | 2.17B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Income | -26.49M | -16.49M |
| EPS (Diluted) | -0.14 | -0.08 |
| Gross Profit | 0.0 | 0.0 |
| Operating Income | -26.78M | -17.32M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 |
|---|---|---|
| Total Assets | 59.38M | 18.46M |
| Total Liabilities | 4.72M | 3.84M |
| Shareholders' Equity | 54.67M | 14.62M |
| Total Debt | 0.0 | 786,000.0 |
| Cash & Equivalents | 53.08M | 16.30M |
| Current Assets | 55.54M | 17.56M |
| Current Liabilities | 4.72M | 3.05M |